| GA23358-005mg |
|
81858-94-8 |
Peptide YY (canine, mouse, porcine, rat)
|
0 |
C190H288N54O57 |
|
|
|
| GA23357-1mg |
|
86895-09-2 |
Peptide YY (13-36) (canine, mouse, porcine, rat)
|
0 |
C135H209N41O38 |
|
|
|
| GA23357-005mg |
|
86895-09-2 |
Peptide YY (13-36) (canine, mouse, porcine, rat)
|
0 |
C135H209N41O38 |
|
|
|
| GA23356-5mg |
|
115136-18-0 |
|
0 |
C72H116N18O24S |
|
|
|
| GA23356-1mg |
|
115136-18-0 |
|
0 |
C72H116N18O24S |
|
|
|
| GA23355-005mg |
|
1872441-58-1 |
|
0 |
C262H415N73O72S2 |
|
|
|
| GA23355-001mg |
|
1872441-58-1 |
|
0 |
C262H415N73O72S2 |
|
|
|
| GA23354-1mg |
|
863608-35-9 |
|
0 |
C140H202N36O33S |
|
|
|
| GA23354-005mg |
|
863608-35-9 |
|
0 |
C140H202N36O33S |
|
|
|
| GA23353-5mg |
|
214556-79-3 |
|
0 |
C104H169N35O19S |
|
|
|
| GA23353-1mg |
|
214556-79-3 |
|
0 |
C104H169N35O19S |
|
|
|
| GA23352-1mg |
|
— |
PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15)
|
0 |
C66H101N17O29S + PEG30K |
|
|
|
| GA23352-005mg |
|
— |
PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15)
|
0 |
C66H101N17O29S + PEG30K |
|
|
|
| GA23351-5mg |
|
143784-00-3 |
|
0 |
C77H122N20O17 |
|
|
|
| GA23351-1mg |
|
143784-00-3 |
|
0 |
C77H122N20O17 |
|
|
|
| GA23350-25mg |
|
1872435-09-0 |
PAR-3 (1-6) amide (human)
|
0 |
C29H46N10O7 |
|
|
|
| GA23350-5mg |
|
1872435-09-0 |
PAR-3 (1-6) amide (human)
|
0 |
C29H46N10O7 |
|
|
|
| GA23349-100mg |
|
1348395-60-7 |
PAR-2 (1-6) amide (human) (scrambled)
|
0 |
C28H54N8O7 |
|
|
|
| GA23349-25mg |
|
1348395-60-7 |
PAR-2 (1-6) amide (human) (scrambled)
|
0 |
C28H54N8O7 |
|
|
|
| GA23348-100mg |
|
202933-49-1 |
|
0 |
C28H53N7O8 |
|
|
|
